Nursing and Health Professions
Confidence Interval
100%
Silodosin
86%
Man
78%
Adverse Event
52%
Quality of Life
21%
Treatment Withdrawal
21%
Symptom
21%
Alpha Adrenergic Receptor Blocking Agent
17%
Prostate Hypertrophy
13%
Tamsulosin
8%
Side Effect
8%
Alfuzosin
8%
Naftopidil
8%
Placebo
8%
Publication
8%
Systematic Review
8%
Follow up
4%
Data Base
4%
International Prostate Symptom Score
4%
Prostate Volume
4%
Cochrane Library
4%
Scopus
4%
Procedures
4%
Analysis
4%
Medicine and Dentistry
Silodosin
86%
Adverse Event
52%
Treatment Withdrawal
21%
Symptom
21%
Alpha Adrenergic Receptor Blocking Agent
17%
Cardiovascular System
17%
Prostate Hypertrophy
13%
Side Effect
8%
Random Effects Model
8%
Tamsulosin
8%
Alfuzosin
8%
Naftopidil
8%
Therapeutic Procedure
8%
Follow up
4%
International Prostate Symptom Score
4%
Age
4%
Urinary Tract
4%
Analysis
4%
Language
4%
Randomized Controlled Trial
4%
Biochemistry, Genetics and Molecular Biology
Silodosin
86%
Life
21%
Alpha Blocker
17%
Tamsulosin
8%
Alfuzosin
8%
Data Base
4%
Reduction (Chemistry)
4%
Web of Science
4%
Cochrane Library
4%
Taxonomy
4%
Age
4%
Volume
4%
Language
4%
Scopus
4%
Neuroscience
Silodosin
86%
Alpha Blocker
17%
Hyperplasia
13%
Tamsulosin
8%
Alfuzosin
8%
Placebo
8%
Randomized Controlled Trial
4%
Prostate
4%
Psychology
Treatment
30%
Quality of Life
21%
Main Result
4%
Systematic Literature Review
4%
Data Collection
4%
Inconsistencies
4%